Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes

Diagnostic Molecular Pathology

Volumn 10, Issue 4, 2001, Pages 214-222

  Frater, John L ^a   Tsiftsakis, Evangelos K ^a   Hsi, Eric D ^a   Pettay, James ^a   Tubbs, Raymond R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

BCL2; FISH; Follicle center lymphoma; Mantle cell lymphoma

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 18; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MICROSCOPY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DIAGNOSIS, DIFFERENTIAL; DNA PROBES; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, SMALL LYMPHOCYTIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 0035204253     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200112000-00002     Document Type: Article

References (92)

1. A minute chromosome in human granulocytic leukemia
2. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukemia
3. A new characteristic karyotypic anomaly in lymphoproliferative disorders
4. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma
5. Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype
6. Rearrangement of CCNDI (BCL1/PRAD1) 3′ untranslated region in mantle cell lymphomas and t(11q13)-associated leukemias
7. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma
8. Gene rearrangement and over-expression of PRAD1 in lymphoid malignancy with t(11;14) (q13;q32) translocation
9. Translocation (11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage
10. Genotypic characterization of centrocytic lymphoma: Frequent rearrangement of the chromosome 11 BCL1 locus
11. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the BCL1 major translocation center
12. Characterization of a candidate BCL1 gene
13. Human D-type cyclin
14. Translocation of t(11;14) in chronic lymphoid disorders
15. t(11;14) and mantle cell derived lymphomas
16. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis
17. Cytogenetics and molecular genetics in multiple myeloma
18. Cytogenetic study in multiple myeloma
19. Comparison of chromosome analysis and bcl-1 rearrangement in a series of patients with multiple myeloma
20. The (11;14)(q13;q32) translocation in multiple myeloma: A morphologic and immunohistochemical study
21. Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders
22. Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: Correlation with survival
23. Correlations between karyotype and cytologic findings in multiple myeloma
24. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia
25. Cloning of the (11;14)(q31;q32) translocation breakpoints from two human leukemia cell lines
26. Expression of BCL2 and BCL2-Ig fusion transcripts in normal and neoplastic cells
27. BCL2 is an inner mitochondrial membrane protein that blocks programmed cell death
28. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14;18) chromosomal translocation
29. Involvement of the BCL2 gene in human follicular lymphoma
30. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin lymphoma
31. Mantle cell lymphoma
32. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma
33. Refinement of the BCL2/immunoglobulin heavy chain gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets
34. A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma
35. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification
36. Detection of chromosomal translocation t(14;18) within the minor cluster region of BCL2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas
37. Detection of occult follicular lymphoma by specific DNA amplification
38. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma
39. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
40. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
41. Diagnostic utility of fluorescence in situ hybridization in mantle cell lymphoma
42. Frequent involvement of chromosomes 1, 3, 7, and 8 in splenic marginal zone lymphoma
43. p53 gene deletion predicts poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
44. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCLL compilation of data on 662 patients
45. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia
46. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology
47. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation
48. FISH detection of chromosome 14q32/IgH translocations: Evaluation in follicular lymphoma
49. Detection of 14q32 translocations in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus
50. Translocations and amplifications of the BCL2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome clones
51. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization
52. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes
53. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia
54. Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization
55. Detection of 11q13 rearrangements in hematologic neoplasms by double-color fluorescence in situ hybridization
56. Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization
57. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
58. Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-color interphase fluorescence in situ hybridization
59. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma
60. Rapid visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization
61. Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma
62. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
63. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
64. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders
65. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders
66. BCL1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma
67. Nonrandom chromosomal abnormalities in lymphoma
68. Chromosomal abnormalities in poorly differentiated lymphocytic lymphoma
69. A variant chromosome translocation at 11q13 identifying PRAD1/Cyclin D1 as the BCL1 gene
70. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/intermediate lymphocytic lymphoma?
71. BCL1 gene rearrangements in mantle cell lymphomas: A comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and southern transfer analysis
72. Bone marrow and peripheral blood involvement in mantle cell lymphoma
73. Polymerase chain reaction detection of the t(11;14) translocation involving the BCL1 major translocation cluster in mantle cell lymphoma
74. Rearrangement and overexpression of the BCLI/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias
75. Mantle cell lymphoma: Rapid polymerase reaction-based genotyping of a morphologically heterogeneous entity
76. Cyclin D1 (BCL-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia
77. Multiple breakpoints within the BCL1 locus in B-cell lymphoma: Rearrangements of the cyclin D1 gene
78. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies
79. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas
80. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis
81. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene
82. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow
83. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study
84. Detection of BCL-2 protein and Bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization
85. Expression of the bcl-2 oncogene protein is not specific for the 14;18 translocation
86. Clinical significance of bcl-2 MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases
87. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms
88. BCL2 overexpression in diffuse large B-cell lymphoma
89. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphoma
90. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas
91. Cyclin D1 expression in non-Hodgkin's lymphomas: Detection by immunohistochemistry